Jake Engelmeier, PharmD, RPh

Apellis Pharmaceuticals

Poster(s):

• (361) Real-world demographics, clinical characteristics, and medication utilization in biopsy-confirmed primary C3 glomerulopathy: A 20-year single-center EHR cohort study
  Wednesday, October 29, 2025